Literature DB >> 18577785

Chloroquine: novel uses & manifestations.

R G Cooper1, T Magwere.   

Abstract

Chloroquine (CHQ) is a cheap, relatively well tolerated drug initially developed for the treatment of malaria in the 1930s. CHQ has, however, since accrued a plethora of uses in the treatment and amelioration of several other diseases and conditions because of its lysosomotropic properties. It also has characteristic physiological and systemic effects. This review gives an overview of the history and pharmacology of CHQ, and progresses to consider some of the mechanisms that may underlie its biochemical and physiological effects. Additionally, an overview of some of the novel uses of CHQ in the treatment of viral infections and cancer are presented. The antimalarial mechanisms of CHQ were not discussed in this review. The message is that CHQ, despite its welldocumented toxicity and adverse side effects may have important future uses that are associated with its lysosomotropic and immunomodulatory mechanisms. The possibility exists therefore that CHQ might be re-introduced into regular malaria treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577785

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  23 in total

Review 1.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

2.  Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.

Authors:  R R Winkelmann; Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-01

Review 3.  A bibliometric review of drug repurposing.

Authors:  Nancy C Baker; Sean Ekins; Antony J Williams; Alexander Tropsha
Journal:  Drug Discov Today       Date:  2018-01-09       Impact factor: 7.851

4.  Randomised controlled trial of weekly chloroquine to re-establish normal erythron iron flux and haemoglobin recovery in postmalarial anaemia.

Authors:  Sharon E Cox; Chidi V Nweneka; Conor P Doherty; Anthony J Fulford; Sophie E Moore; Andrew M Prentice
Journal:  BMJ Open       Date:  2013-07-04       Impact factor: 2.692

5.  Antimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC.

Authors:  Johanna M Gostner; Sebastian Schröcksnadel; Kathrin Becker; Marcel Jenny; Harald Schennach; Florian Uberall; Dietmar Fuchs
Journal:  FEBS Open Bio       Date:  2012-08-17       Impact factor: 2.693

6.  Killing of Staphylococcus aureus in murine macrophages by chloroquine used alone and in combination with ciprofloxacin or azithromycin.

Authors:  Somrita Dey; Biswadev Bishayi
Journal:  J Inflamm Res       Date:  2015-01-22

7.  Chloroquine promotes apoptosis in melanoma cells by inhibiting BH3 domain-mediated PUMA degradation.

Authors:  Alexander J Lakhter; Ravi P Sahu; Yang Sun; William K Kaufmann; Elliot J Androphy; Jeffrey B Travers; Samisubbu R Naidu
Journal:  J Invest Dermatol       Date:  2013-01-31       Impact factor: 8.551

8.  Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer.

Authors:  Wieslawa H Dragowska; Sherry A Weppler; Jun Chih Wang; Ling Yan Wong; Anita I Kapanen; Jenna S Rawji; Corinna Warburton; Mohammed A Qadir; Elizabeth Donohue; Michel Roberge; Sharon M Gorski; Karen A Gelmon; Marcel B Bally
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

9.  Chloroquine or chloroquine-PI3K/Akt pathway inhibitor combinations strongly promote γ-irradiation-induced cell death in primary stem-like glioma cells.

Authors:  Elke Firat; Astrid Weyerbrock; Simone Gaedicke; Anca-Ligia Grosu; Gabriele Niedermann
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

10.  In vitro antimalarial activity of different extracts of Eremostachys macrophylla Montbr. & Auch.

Authors:  Solmaz Asnaashari; Fariba Heshmati Afshar; Atefeh Ebrahimi; Sedigheh Bamdad Moghadam; Abbas Delazar
Journal:  Bioimpacts       Date:  2015-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.